Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer
Ontology highlight
ABSTRACT: NO-CUT is a one-stage phase II trial seeking to establish whether an oxaliplatin-based chemotherapy preceding standard neo-adjuvant fluoropyrimidines-based chemo radiotherapy, can safely spare demolitive surgical intervention in patients with operable rectal cancer, without increasing the risk of distant relapse. The trial also has a translational component aimed at establishing whether selected genomic, epigenetic, and transcriptomic markers are predictive of tumor and patient outcome.
DISEASE(S): Colorectal Adenocarcinoma,Rectal Neoplasms,Adenocarcinoma Of The Medium/lower Rectum In Stage Ii (ct3-4 N0) Or Stage Iii (ct1-4, N1-2),Adenocarcinoma Del Retto Medio/basso In Stadio Ii (ct3-4 N0) O Iii (ct1-4, N1-2),Colo-rectal Cancer
PROVIDER: 2275988 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA